Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Desmopressin recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Desmopressin (16 total). Check the affected lots below.

Most common reason: cGMP deviation (5 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Desmopressin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Desmopressin recalls in 2026

1 initiated in 2026, 16 in total — newest first
Class II · Moderate risk

Desmopressin Nasal Spray

Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.

Ongoing Packaging defect Apotex Corp. NDC 60505-0815-0 D-0510-2026
Class II · Moderate risk

Desmopressin Acetate Injection USP

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Terminated Sterility / contamination Teva Pharmaceuticals USA NDC 0703-5051-01 D-0272-2021
Class III · Low risk

Desmopressin Acetate Tablets

Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.

Terminated Labeling / mix-up American Health Packaging D-1235-2015
Class III · Low risk

Desmopressin Acetate Tablets

Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.

Terminated Labeling / mix-up Actavis Laboratories, FL, Inc. D-1285-2015
Class II · Moderate risk

Desmopressin Acetate active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-620-2015
Class II · Moderate risk

Desmopressin Acetate

Labeling: Label Mixup: DESMOPRESSIN ACETATE, Tablet 0.1 mg may have potentially been mislabeled as the following drug: LOXAPINE, Capsule, 5 mg, NDC 00591036901, Pedigree: AD46426_7, EXP: 5/15/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-968-2014